Covered Stocks

Alex Schwartz

Work

Analyst Alex Schwartz is focused on the Healthcare sector with 18 price targets and ratings documented since 2017 spanning on 2 stocks. Previously, Alex Schwartz worked at STIFEL. Analyst's average stock valuation to be materialised ratio is 25% with an average time for price targets to be met of 94 days.

Most recent stock forecast was given on PBYI, Puma Biotechnology, Inc at 11-May-2018.

Alex Schwartz best performing recommendations are on PBYI (PUMA BIOTECHNOLOGY, INC).
The best stock recommendation documented was for PBYI (PUMA BIOTECHNOLOGY, INC) at 10/2/2017. The price target of $130 was fulfilled within 32 days with a profit of $10.15 (8.47%) receiving and performance score of 2.65.

Average potential price target upside

ESPR PBYI

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Sell

9

$3.1 (52.54%)

9

3 days ago

5/11 (45.45%)

$7.66 (18.19%)

35

Hold

6

$0.1 (1.69%)

6

6 months 3 days ago

10/18 (55.56%)

$11.46 (48.40%)

186

Sell

6

$0.1 (1.69%)

6

9 months 1 days ago

9/11 (81.82%)

$11.99 (44.42%)

65

Sell

5

$-0.9 (-15.25%)

8

11 months 21 days ago

9/9 (100%)

$-2.35 (-3.35%)

32

Buy

12

$6.1 (103.39%)

1 years 1 months 29 days ago

6/12 (50%)

$25.86 (62.45%)

106

Show more analysts
ESPR PBYI